Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

I think we know the answer as well as does Menon or Shapiro or anybody

Which is that NOBODY knows how well it might work because it has not been given in the ways it will in the near future: 1) multiple x per week dosing at higher levels, and 2)given in combo with many other possible agents. Ovarian CA trial will be the first time we get a real look at where Kevetrin may find its place in the hematology/oncology universe

Toward that end: any update on ovarian CA trial? Any update on any other combination trial- renal cell CA trial at Beth Israel, for example?

Most basic question: has there been a final decision on ovarian CA trial for the dosing of Kevetrin? 750 3x week? Or is this still undecided? 2x week or every other day or use a pump or whatever?